CCO Treatment Updates
Evolving Treatment Options and Future Directions in Mantle Cell Lymphoma
State-of-the-Art First-line Treatment of MCL: Current and Novel Approaches |
Module 1 of 4 |
- Andrew D. Zelenetz, MD, PhD
|
|
|
Andrew D. Zelenetz, MD, PhD, reviews the latest data on current and novel therapeutic approaches for frontline treatment of mantle cell lymphoma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Cite the latest data on prognostic indicators for survival among patients with mantle cell lymphoma
- Review clinical trials data evaluating the role of rituximab in combination with standard or dose-intense chemotherapy regimens for the first-line treatment of mantle cell lymphoma
- Discuss the safety and efficacy of adding radioimmunotherapy to chemotherapy regimens or in the setting of stem cell transplantation
- Analyze results of recent clinical trials investigating the incorporation of newer agents into mantle cell lymphoma treatment
Abstract
|
New Options for the Treatment of Relapsed Mantle Cell Lymphoma |
Module 2 of 4 |
|
|
|
Steven H. Bernstein, MD, explores current recommendations and options for the treatment of advanced mantle cell lymphoma and discusses what recent clinical trial results may signify for patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply proteasome inhibitors in the clinical management of patients with relapsed/refractory mantle cell lymphoma
- Contrast stem cell transplantation strategies in the treatment of relapsed/refractory mantle cell lymphoma
- Discuss current data on second-line treatment strategies for patients with relapsed/refractory mantle cell lymphoma
- Interpret results of clinical trials that evaluate the use of investigational agents for the treatment of mantle cell lymphoma
Abstract
|
The Role of Maintenance Therapy and Individualization of Therapy in Mantle Cell Lymphoma |
Module 3 of 4 |
|
|
|
Sven de Vos, MD, PhD, reviews the current status of maintenance therapy for mantle cell lymphoma and explores new developments in prognostic measures and markers that may lead to the individualization of therapy.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare agents currently used as maintenance therapy in the treatment of mantle cell lymphoma
- Describe novel agents with promise as maintenance therapy in the setting of mantle cell lymphoma
- Contrast prognostic indices and markers used in the treatment of mantle cell lymphoma
- Discuss genomic and proteomic analysis techniques of potential utility in the treatment of mantle cell lymphoma
Abstract
|
Practical Nursing Management Considerations in Mantle Cell Lymphoma |
Module 4 of 4 |
- Amy Goodrich, RN, MSN, CRNP-AC
|
|
|
Amy Goodrich, RN, MSN, CRNP-AC, reviews current strategies to optimally manage therapy-related adverse effects in patients with mantle cell lymphoma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Employ the optimal management strategies for treatment-related complications such as peripheral neuropathy, gastrointestinal toxicities, and hypersensitivity reactions in patients with mantle cell lymphoma
- Identify the types of hematologic toxicities associated with therapies administered to patients with mantle cell lymphoma and the approaches to managing these toxicities
- Evaluate the role of stem cell transplantation in mantle cell lymphoma and the potential complications associated with this approach
|
CCO Slidesets
Evolving Treatment Options and Future Directions in Mantle Cell Lymphoma
 |
|
Download slides on the current therapies and novel approaches for mantle cell lymphoma in the frontline and relapsed/refractory settings, and on the role of maintenance therapy in treating patients with this disease. The role of biomarkers in the individualization of therapy also is explored in this slideset.
Format: Microsoft PowerPoint (.ppt) |
File size: 2.14 MB
| Date posted: 6/22/2009
|
Practical Nursing Management Considerations in Mantle Cell Lymphoma
 |
|
Download slides on important nursing considerations for patients who are receiving medical therapy for mantle cell lymphoma.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.35 MB
| Date posted: 6/12/2009
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|